Skip to main content
. 2016 Aug;7(4):595–602. doi: 10.21037/jgo.2016.04.02
Trial ID (Number; First author; Year of publication):
Action
Methods
Country: Study setting: Duration: Funding:
Allocation: Blindness:
Participants
Study population (average/increased risk/high risk individuals):
Number of participants (N): Number of participants in each group: Age:
Sex: Ethnicity Included: Excluded:
Interventions Evaluated
Comparators:
Outcomes:
Incidence/recurrence of new adenoma: Incidence of colorectal cancer:
Incidence of adverse events: Compliance rate:
Drop-outs (reason):
Outcomes – unable to use –and WHY
Results:
Notes: